SuperGen to Present at Bear Stearns Annual Healthcare Conference September 11th

Thursday, September 6, 2007 General News J E 4
DUBLIN, Calif., Sept. 6 SuperGen, Inc.(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapiddevelopment and commercialization of therapies for solid tumors andhematological malignancies, today announced that James S. Manuso, Ph.D.,President and Chief Executive Officer, is scheduled to present at the BearStearns Annual Healthcare Conference on September 11, 2007, at The Grand Hyattin New York.

SuperGen's presentation at the Bear Stearns Annual Healthcare Conferenceis scheduled to begin at 4 p.m. EDT. A live webcast of the presentation willbe available on the investor relations section of the Company's Web site The webcast will be archived for 90 days.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery, rapid development and commercialization oftherapies for solid tumors and hematological malignancies. SuperGen isdeveloping a number of therapeutic anticancer products focused on kinase andcell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit Timothy L. Enns Mary M. Vegh SuperGen, Inc. SuperGen, Inc. SVP, Corporate Communications & Manager, Investor Relations Business Development Tel: (925) 560-2845 Tel: (925) 560-0100 E-mail: E-mail:

SOURCE SuperGen, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Saatchi & Saatchi Consumer Healthcare Becomes Saat...
Sensitech to Present at IQPC's Fifth Annual Cold C...